Skip to main content
JARO: Journal of the Association for Research in Otolaryngology logoLink to JARO: Journal of the Association for Research in Otolaryngology
. 2026 Mar 6;27(3):343–359. doi: 10.1007/s10162-026-01034-2

The Cochlear Lateral Wall as a Biological Battery: the Mechanisms Underlying K+ Transport and Potential Generation

Fumiaki Nin 1,2,✉, Hiroshi Hibino 3,4,5,✉
PMCID: PMC13237396  PMID: 41792388

Abstract

The cochlea possesses an exceptional capacity for rapid sensory transduction, enabling sound perception of at frequencies exceeding 15 kHz. This extraordinary performance depends on a specialized electrochemical environment that maintains a high endocochlear potential (EP) and facilitates efficient K⁺ circulation. The cochlear lateral wall serves as a central component, functioning as a biological battery that generates and sustains the EP via intricate ion transport mechanisms. It consists of two epithelial-like layers—the marginal cell layer and the syncytial layer—which are electrically insulated by tight junctions and interconnected via gap junctions. K⁺ enters hair cells from the K⁺-rich endolymph to initiate sensory transduction and is subsequently recycled through the perilymph and reabsorbed by the lateral wall. Our combined electrophysiological and mathematical modeling studies elucidate that the EP primarily depends on K⁺ equilibrium potentials across the apical membranes of intermediate and marginal cells, primarily mediated by Kir4.1 and IKs channels, respectively. Pharmacological experiments confirmed that Na⁺,K⁺-ATPase and NKCC are essential for maintaining the K⁺ gradient and EP. Furthermore, our computational model successfully reproduced dynamic changes in ion concentrations and membrane potentials under hypoxic conditions and acoustic stimulation. Genetic studies further reinforce the physiological importance of lateral wall components, as mutations in associated transporters, channels, and structural proteins commonly lead to sensorineural hearing loss. Collectively, these findings underscore the cochlear lateral wall as an integrated electrochemical organ and illustrate the utility of multiscale modeling in bridging molecular mechanisms with systems-level auditory function.

Keywords: Stria vascularis, Cochlea

Introduction

The cochlea, a specialized peripheral auditory organ, is notable for its exceptionally rapid sensory transduction compared to other sensory systems. For instance, photoreceptors in the retina, the peripheral organ of vision, respond at approximately 10 to 30 Hz [25], which limits the refresh rate of typical displays to less than 150 Hz. In contrast, cochlear hair cells, the primary auditory receptor cells, can detect sounds reaching up to 20 kHz [53] and exhibit a response speed exceeding 40 kHz. This performance is approximately 100 times faster than the maximal firing rate of neurons (~ 500 Hz) and nearly 1,000 times faster than that of photoreceptors. This characteristic is achieved through specialized mechanisms that distinguish hair cells from conventional excitable cells [53].

In typical excitable cells such as neurons and muscle fibers, excitation is mediated by Na⁺ influx through voltage-gated channels, followed by Na⁺ extrusion via Na⁺,K⁺-ATPase to restore ionic gradients [3, 53]. This coupling between fast ion influx and enzymatic ion extrusion limits the maximum excitation frequency to ~ 500 Hz. In contrast, cochlear hair cells employ ion channels not only for ion influx but also for efflux, enabling significantly faster cycles of excitation [53]. The cochlear architecture and its surrounding electrochemical milieu are optimized to support this ultrafast transduction.

Sound Reception by Hair Cells and the Electrochemical Environment Maintenance System “K+ Circulation in the Cochlea”

A defining feature of the cochlea is the unique lymphatic environment surrounding the hair cells. The cochlear duct is filled with two distinct extracellular fluids: endolymph and perilymph [42, 43, 79, 108, 109]. Incoming sound vibrations from the external environment are transmitted to sensory epithelium, which is immersed in both fluids—perilymph below and endolymph above (Fig. 1a). These vibrations are on the nanometer scale, comparable in magnitude to the size of a single water molecule. Located atop the basilar membrane, the organ of Corti houses the sensory hair cells. The basolateral membranes of these cells are bathed in perilymph, whereas their apical hair bundles extend into the K⁺-rich endolymph [53] Endolymph is a highly specialized extracellular fluid characterized by a high potassium concentration of approximately 150 mM [93, 96] and a markedly positive endocochlear potential (EP) of + 80 mV [5, 64, 106] (Fig. 1a).

Fig. 1.

Fig. 1

Structure of the inner ear cochlea, cochlear lateral wall, and K+ ion environment. (a) Cross-sectional view of the cochlea. The cochlear lateral wall consists of the stria vascularis and the spiral ligament. (b) Magnified view of the cochlear lateral wall (dashed square in (a)) and detailed diagram of the syncytium layer. Transport molecules involved in K+ unidirectional transport and the generation of the endocochlear potential (EP) are also shown. Functionally, the cochlear lateral wall consists of two layers: a syncytium layer with fibrocytes forming the spiral ligament and intermediate and basal cells forming the stria vascularis, which are connected by gap junctions. Tight junctions between basal cells isolate the intrastrial space (IS) from the perilymph. The second layer is the marginal cell layer, where tight junctions between marginal cells electrically separate the IS from the endolymph. (c) Changes in the potential and K+ ionic environment in the cochlear compartments under various loading conditions.

Adapted from reference [79]. IS intrastrial space, NKCC Na+, K+, 2Cl− cotransporter, TJ tight junction

When the basilar membrane vibrates, the deflection of hair bundles opens mechanosensitive cation channels at their tips, allowing K⁺ to enter the hair cells from the endolymph. This K⁺ influx depolarizes the hair cells, thereby converting mechanical stimuli into electrical signals that are relayed to the central nervous system via neurotransmitter release from the basolateral membrane [47]. The + 80 mV EP provides a substantial electrochemical gradient across the hair cell membrane, enhancing K⁺ influx and thereby augmenting auditory sensitivity [17, 27, 45]. Disruption or loss of this potential is strongly associated with hearing impairment [27, 45, 50, 61].

Another distinctive feature of the cochlea is the presence of a specialized K⁺ recycling system [108], also known as the “K⁺ circulation” system (Fig. 1a) [77, 79, 119]. In this system, K⁺ exits hair cells into the perilymph through basolateral K⁺ channels and is subsequently taken up by two epithelial-like cell layers in the lateral wall, which recycle it into the endolymph [26, 42, 43, 56, 57, 79, 108, 109]. In typical excitable cells, Na⁺ influx triggers excitation and is counterbalanced by Na⁺/K⁺-ATPase–mediated recirculation. By contrast, the K⁺ circulation in the cochlea operates constitutively, because mechanosensitive channels in hair cells remain partially open even in the absence of acoustic stimulation, allowing continuous cation permeation [22, 119].

The cochlear lateral wall is composed of the stria vascularis, which is densely vascularized, and the spiral ligament as connective tissue, consisting of fibrocytes. Unidirectional K⁺ transport through the lateral wall—particularly involving the stria vascularis—has long been proposed as a key mechanism for maintaining both the EP and K⁺ circulation [61, 63, 102], although the precise molecular underpinnings remained poorly defined. The stria vascularis comprises three main cell types: marginal, intermediate, and basal cells (Fig. 1b). Intermediate and basal cells, along with adjacent fibrocytes in the spiral ligament, form a functional electrochemical syncytium. This syncytium exhibits uniform ionic and electrical properties due to extensive coupling via gap junctions, which likely facilitate intercellular ion flow [56, 57, 65, 94, 98, 107–109]. In contrast, tight junctions between marginal cells and between basal cells serve as electrical barriers, similar to those in renal and intestinal epithelia (Fig. 1b). Therefore, the lateral wall may be functionally conceptualized as comprising two epithelial-like layers: an inner layer of marginal cells and an outer syncytial layer consisting of intermediate cells, basal cells, and fibrocytes (Fig. 1b).

Histological, pharmacological, and electrophysiological studies have revealed that key K⁺ transporters—including Na⁺,K⁺-ATPase and the Na⁺,K⁺,2Cl⁻ cotransporter (NKCC)—are localized to the basolateral membranes of both epithelial-like layers [26, 62, 66, 72]. In contrast, Kir 4.1 and IKs channels are expressed at the apical membrane of the inner and outer layers, respectively [4, 87] (Fig. 1b).

This review article presents recent insights from our experimental and computational studies that describe the roles of K⁺ transport molecules in mediating unidirectional K⁺ movement across the cochlear lateral wall. We further discuss the mechanisms by which these transport processes contribute to generation and maintenance of the EP.

K+ Equilibrium Potential

To aid in understanding how the endocochlear potential (EP) is generated, we begin by briefly explaining the concept of the “K⁺ equilibrium potential,” a fundamental electrochemical principle underlying EP formation [53]. As illustrated in Fig. 2a, consider two compartments: space A with a high K⁺ concentration and space B with a low K⁺ concentration. Each compartment contains an equal total number of cations and anions. If the two spaces are separated by an impermeable membrane, no ionic movement occurs (Fig. 2a). However, if the membrane is selectively permeable to K⁺, K⁺ ions will diffuse from A to B along their concentration gradient. As K⁺ moves, positive charge accumulates in space B, creating an electrical potential difference across the membrane. This emergent potential counteracts further K⁺ movement. Eventually, an electrochemical equilibrium is established—when the driving force from the concentration gradient is exactly balanced by the opposing electrical gradient. The resulting potential is called the “K⁺ equilibrium potential” or “K⁺ diffusion potential,” and its magnitude depends on the K⁺ concentration ratio between the two compartments.

EK=RTFln([K+]A/[K+]B)→(a)

Fig. 2.

Fig. 2

Generation of the K+ equilibrium potential. (a) When a membrane separates two compartments, space A and space B, with a higher concentration of K⁺ in space A and a lower concentration in space B, and the total number of cations and anions in each space is balanced by ions other than K⁺, selective permeability to K⁺ allows its diffusion down the concentration gradient. This movement results in a net transfer of positive charge, generating a potential difference across the membrane such that space B becomes electrically positive relative to space A. As K⁺ continues to move, the emerging electrical potential increasingly opposes further K⁺ efflux. Eventually, an electrochemical equilibrium is established when the electrical driving force exactly counterbalances the chemical gradient. The resulting membrane potential at this equilibrium is termed the "K⁺ equilibrium potential," and its magnitude is determined by the K⁺ concentration gradient between the two spaces. (b) This membrane potential can be conceptually represented by an electrical circuit model, wherein the membrane functions as a capacitor, and the ion gradient is modeled as a battery with an electromotive force. Ionic permeability is represented as a resistance

Here, EK denotes the K⁺ equilibrium potential, R is the universal gas constant, T is the absolute temperature, F is the Faraday constant, and [K⁺]A and [K⁺]B represent the K⁺ concentrations in compartments A and B, respectively. In biological systems, the K⁺-selective permeability of membranes is conferred by K⁺ channels—transmembrane proteins that allow the selective passage of K⁺. This principle also applies to other monovalent ions. Understanding the quantitative relationship between ion concentration gradients and membrane potentials, as described by this equation, is key to elucidating the mechanisms by which the EP is generated, as detailed in the sections below.

Conversely, in the same equation, if [K⁺]A is unknown but [K⁺]B and the K⁺ equilibrium potential are known, one can solve for the unknown concentration, making this equation a practical tool for estimating ion concentrations in biological experiments. In particular, ion-selective electrodes exploit this principle to measure K⁺ concentration based on recorded membrane potentials. Moreover, membrane potentials and associated ionic fluxes can be conceptualized using an equivalent electrical circuit model, wherein the membrane behaves like a capacitor connected to a resistor and an electromotive force (i.e., a “battery”) driven by the transmembrane concentration gradient (Fig. 2b). We adopted this equivalent circuit framework in our previously developed mathematical models of cochlear ion transport [77, 78].

Characteristics of the Cochlear Lateral Wall and Mechanism Underlying the EP

The anatomical and electrochemical features of the cochlear lateral wall can be summarized as follows:

  1. Tight junctions connecting the inner and outer epithelial layers, as well as vascular endothelial cells, electrically insulate the stria vascularis from the perilymph, endolymph, and bloodstream.

  2. These tight junctions also delineate the basolateral and apical membranes of epithelial cells, enabling the electrical properties of the lateral wall to be described in terms of four distinct membrane domains: the apical and basolateral membranes of both the inner and outer layers.

  3. The basolateral membrane of the inner layer and the apical membrane of the outer layer form a highly folded, interdigitating structure that encloses a narrow extracellular compartment termed the “intrastrial space (IS),” approximately 15 nm in width (Fig. 1b)[44]. The IS contains extracellular fluid with a relatively low K⁺ concentration (below 5 mM), similar to other extracellular spaces, but maintains a high electrical potential of approximately + 90 mV—comparable to the endolymphatic potential (Fig. 1c)[48, 76, 88]. This “intrastrial potential” (IS potential), which was suggested to depend primarily on K+ permeability on the apical membrane of the outer layer, is widely regarded as the primary electrochemical driver of the endolymphatic potential [88]. This idea is supported by an observation that vascular perfusion of Ba2+, a blocker for K+ channels, markedly suppressed the EP [72]. The K+ channels crucial for formation of the EP was identified as an inwardly rectifying K.+ channel Kir4.1 expressed in stria vascularis [41]. Later, a histochemical study revealed that Kir4.1 is localized on the apical membrane of the outer layer, suggesting that this channel plays a central role in generation of the IS potential [4, 48, 76, 88, 99]

To examine the mechanisms responsible for generating the high endolymphatic potential, we performed in vivo measurements using double-barreled K⁺-selective ion electrodes inserted into microdomains within and adjacent to the cochlear lateral wall of guinea pigs. This technique allowed for simultaneous recording of K⁺ concentration and electrical potential under various experimental conditions [48, 76, 88].

Our results demonstrated that the highly positive EP is primarily driven by K⁺ equilibrium potentials generated across the apical membranes of both the inner and outer layers (Fig. 1b; syncytial: Kir4.1; marginal: IKs) [76]. These equilibrium potentials arise likely from the electrochemical gradients of K⁺ across the respective apical membranes [99, 101]. Under physiological conditions, the K⁺ concentration is markedly lower in the IS than in the syncytial layer, creating a large K⁺ equilibrium potential at the syncytial apical membrane. Conversely, the K⁺ concentrations in the marginal layer and endolymph are both high, resulting in a negligible potential difference across the apical membrane of marginal cells. Thus, the IS potential substantially accounts for the high endolymphatic potential (Fig. 1c, first row). However, under hypoxic conditions, which mimics experimentally inhibition of Na⁺,K⁺-ATPase in marginal cells [75, 86], we observed K⁺ accumulation in the IS and K⁺ depletion in the marginal cell layer, reducing the outer layer equilibrium potential and increasing that of the inner layer. This shift ultimately reversed the endolymphatic potential to negative values (Fig. 1c, second row) [76].

To illustrate this, we present experimental data in Fig. 3a, depicting simultaneous measurements of electrical potential and K⁺ concentration as a K⁺-selective electrode was advanced from the perilymph into the stria vascularis. As the electrode progressed from the low-K⁺, 0 mV perilymph and passed through the outer layer, which contains numerous fibrocytes, transient and multiple elevations in K⁺ concentration were observed. A distinct region was then identified with a stable K⁺ concentration of 65–85 mM and a slightly positive potential of + 2 to + 3 mV. This domain corresponds to the syncytial layer under baseline or normoxic conditions (see Fig. 1c).

Fig. 3.

Fig. 3

Measured cochlear lateral wall environment upon inhibition of inner layer Na+,K+-ATPase. (a) Measurement of K+ concentration and potential in each region of the stria vascularis using a K+-selective microelectrode. The red line represents the potential, whereas the blue line shows the change in K+ concentration. The Na+,K+-ATPase in the marginal cell layer was inhibited by anoxia and the infusion of ouabain. The change in K+ concentration in the intrastrial space (IS) under anoxia and the measured K+ concentration in the syncytium layer (black arrow in (a)) were substituted into the equation for (b) in the text, and compared with the measured IS potential (red and orange lines) [43, 76, 79].

Adapted from reference

As the electrode advanced further, it entered the IS, which exhibited a high potential of + 70 mV and a low K⁺ concentration of approximately 4 mM (Fig. 3a; see Fig. 1c). Upon induction of hypoxic conditions, the IS potential dropped markedly from + 70 mV to + 22 mV, while K⁺ concentration increased from 4 to 28 mM [76]. Intermediate cells, forming the apical membrane of the syncytial layer, express the K⁺ channel Kir4.1 at high levels. As such, the IS potential is predominantly governed by the K⁺ equilibrium potential across this membrane. Based on the Nernst-like relation in Eq. (a), the IS potential (ISP) can be expressed as:

ISP≈VSB+RTFln(aK+SY/aK+IS)→(b)

where VSB represents the electrical potential at the basolateral membrane of the syncytial layer, and aK⁺SY and aK⁺IS correspond to the potassium activities in the syncytial layer and IS, respectively. Because VSB and aK⁺SY remain constant under hypoxic conditions, we substituted their measured values—as indicated by the black arrow in the upper panel of Fig. 3a—into Equation (b). We then incorporated the experimentally observed changes in aK⁺IS under hypoxia and compared the resulting calculated ISP with the observed values (Fig. 3a: predicted ISP). These analyses revealed that the IS potential is predominantly governed by the K⁺ equilibrium potential generated by Kir4.1 channels expressed in the syncytial layer [100].

Moreover, perfusion with bumetanide, an NKCC inhibitor acting on the basolateral membrane of the marginal cell layer, produced effects similar to those observed under hypoxic conditions [76]. A comparable shift was noted in the potential across the apical membrane of marginal cells, prompting the derivation of the following expression:

EP≈ISP+VMB+RTFln(aK+MC/aK+EL)→(c)

Here, VMB represents the potential at the basolateral surface of the marginal cell layer, whereas aK⁺MC and aK⁺EL denote the potassium activities in the marginal cell cytoplasm and the endolymph, respectively.

By integrating Eqs. (b) and (c), and assuming that VSB and VMB remain constant under physiological and pathophysiological conditions, we conclude that the EP is governed by two sequential K⁺ equilibrium potentials—one across the syncytial layer and the other across the marginal cell layer. This yields the following comprehensive expression (Fig. 3b) [76]:

EP≈VSB+VMB+RTFln(aK+SY/aK+IS)+RTFln(aK+MC/aK+EL)→(d)

K+ Transport in the Spiral Ligament and the Generation of theHighly Positive EP

The basolateral surface of the syncytial layer in the cochlear lateral wall is composed primarily of fibrocytes within the spiral ligament. Histological analyses have identified several K⁺ uptake transporters in these cells, among which Na⁺,K⁺-ATPase and NKCC likely play prominent roles in K⁺ transport and in generating the high endolymphatic potential [24, 42, 56, 57, 75, 98, 108]. However, the exact contributions of these transporters to EP generation had remained unclear. To address this, we perfused specific transporter inhibitors into the perilymph and transiently inserted a K⁺-selective ion electrode into the syncytial layer to monitor K⁺ concentration and potential changes (Fig. 4). At the same time, a conventional microelectrode was placed in the endolymph to continuously record the EP [1, 113, 114].

Fig. 4.

Fig. 4

K+ transport in the syncytium layer. (a-d) Measurement of K+ concentration and potential in cochlear lateral wall following ouabain perfusion, an inhibitor of Na+,K+-ATPase. The EP was monitored using a conventional glass electrode (d), while K+ concentration and potential were simultaneously measured using a K+ electrode temporarily inserted three times from the perilymph towards the endolymph (a, b, c). The timing of each insertion is indicated by the rectangle in (d). The circles in a, b, and c represent the regions that are considered to depict the typical environment within the syncytium. Compared to pre-perfusion (a), the K+ concentration in the syncytium layer gradually decreased during infusion (b, c).

Adapted from [114] [114]. (e–h) Effect of bumetanide, an inhibitor of NKCC, infused into the perilymph. The same experimental methodology as in (a-d) was used. Compared to pre-perfusion (e), little change was observed in the K+ concentration in the syncytium layer during infusion (f, g). However, it is noteworthy that the EP gradually decreased. (i-l) Effect of low-Na+ solution infused into the perilymph. Compared to pre-perfusion (i), the potential in the basal side of the syncytium layer decreased during infusion (j) and recovered (k). Adapted from [113]

We first examined the effect of ouabain, a potent inhibitor of Na⁺,K⁺-ATPase (Fig. 4a-d). Under control conditions using drug-free artificial perilymph, the EP was maintained at approximately + 80 mV (Fig. 4a). Insertion of a K⁺-selective electrode from the perilymph into the cochlear wall revealed multiple peaks in K⁺ concentration corresponding to fibrocyte-rich regions (Fig. 4a). The K⁺ concentration just proximal to the IS was 70.7 mM, consistent with the outer syncytial layer. Following ouabain perfusion, the EP gradually declined and stabilized near 0 mV. Re-insertion of the K⁺-selective electrode revealed a progressive reduction in K⁺ concentration within the syncytial layer, eventually falling to 10.9 mM (Fig. 4b and c). These findings indicate that Na⁺,K⁺-ATPase mediates K⁺ uptake into the syncytial layer, thereby sustaining its high intracellular K⁺ level. Inhibition of this transporter diminished the K⁺ equilibrium potential across the apical surface of the syncytial layer, ultimately abolishing the EP (see Fig. 1c, third row).

If NKCC were similarly involved in K⁺ uptake, its inhibition by bumetanide would be expected to exert effects comparable to those of ouabain. Interestingly, although bumetanide application reduced the EP (Fig. 4h), it did not significantly alter either the potential or K⁺ concentration within the syncytial layer (Fig. 4e-g; see Fig. 1c, fourth row). These observations suggest that NKCC localized at the basolateral surface of the syncytial layer contributes minimally to K⁺ transport. Further analysis revealed that bumetanide applied to the perilymph reached the stria vascularis, where it inhibited NKCC in the marginal cell layer, thereby leading to a loss of EP (Fig. 1c, fourth row). Additionally, perfusion with a low-Na⁺ solution decreased both the basolateral potential of the marginal cell layer and the EP, implying that Na⁺ permeability is substantially greater than that of K⁺ or Cl⁻ (Fig. 4i-l; see Fig. 1c, fifth row). Together, these findings indicate that Na⁺,K⁺-ATPase is the principal mediator of K⁺ uptake and intracellular K⁺ maintenance in the basal region of the syncytial layer. Notably, while it is generally accepted that cells in vivo maintain a negative resting membrane potential, the membrane potential in this layer is constantly positive by several mV with reference to perilymph, owing to a significant Na+ conductance, a factor crucial for EP generation [1, 79, 113, 114]. The molecular identification of this Na+ conductance represents the final key to fully elucidate the mechanism underlying EP generation. Recent literature suggests that NBCn1 (SLC4A7), NBCn2 (SLC4A10), and NaBC1 (SLC4A11) may be the responsible molecules (Table 1), necessitating further investigation [12, 13, 19, 40, 80].

Table 1.

Genes encoding lateral-wall’s proteins associated with hearing loss in humans and mice

Molecules Distribution Human deafness types Mouse phenotypes (other than deafness) Reference
KCNE1 (Isk, min K) MC Jarvell and Lange-Nielsen syndrome Collapse of SM and VES, balance disorder [87, 92, 105]
KCNQ1 (KvLQT1, Kv7.1) MC Jarvell and Lange-Nielsen syndrome Collapse of SM and VES, balance disorder [15, 92]
KCNJ10 (Kir4.1) IC EAST syndrome, SeSAME syndrome Collapse of SM, loss of EP (~ 0 mV) [10, 73, 84, 89, 99]
KCNK5 (K2P5.1) OSC - Loss of EP (~ + 50 mV), degeneration of hair cells and spiral ganglions [16]
ZBTB20 OSC - Abnormal root cell differentiation, hearing loss [112]
BSND (Barttin) MC Type 4 Bartter's syndrome Loss of EP (~ + 17 mV) [32, 81] [9]
NKCC1 (SLC12A1) MC, FC - Collapse of SM and VES, balance disorder [29, 31, 36]
Pendrin (SLC26A4) SPEC, OSC Pendred syndrome, DFNB4 Loss of EP (~ 0 mV), Gene therapy restored EP and hearing [2, 33–35, 46, 51, 58, 83, 91, 110]
SLC22A4 StE DFNB60 - [6]
KCC3 (SLC12A6) FC - Degeneration of hair cells [11]
HGF LW DFNB39 Defective neural crest cell migration, reduced EP [74]
CHD7 LW Enlarged vestibular aqueduct, hearing loss Structural abnormalities in lateral wall, hearing loss [82]
GJA1 (Cx43) FC AR-nonsydromic deafness - [70, 97]
GJB1 (Cx32) FC X-linked Charcot-Marie-Tooth and deafness - [95]
GJB2 (Cx26) FC DFNB1, DFNA3A, hereditary palmoplantar keratoderma with deafness

Loss of EP (~ + 50 mV),

degeneration of hair cells

[8, 20, 30, 37, 52, 55, 90, 115, 118]
GJB3 (Cx31) FC DFNA2, AR-nonsyndromic deafness - [111]
GJB6 (Cx30) FC DFNA3B Loss of EP (~ + 3 mV), degeneration of hair cells [7, 21, 28, 39, 54, 103]
Panx1 FC, OSC - Loss of EP (~ + 60 mV) [18]
Claudin-11 BC hypomyelinating leukodystrophy (HLD22) Loss of EP (~ + 30 mV), hearing loss [38, 59, 60, 69]
NBCn1 (SLCA7) FC Mild hearing loss, degeneration in organ of Corti, (Na+ conductance) [12, 13, 19]
NBCn2 (SLC4A10) FC Early hearing loss, outer hair cell loss, reduced EP [80]
NaBC1 (SLC4A11) FC Harboyan syndrome Loss of EP (~ + 40 mV), [40]
S1PR2 LW EP decline [49]

EP, endocochlear potential; SM, scala media; VES, vestibular endolymphatic space; FC, fibrocytes; BC, basal cells; IC, intermediate cells; MC, marginal cells; OSC, outer sulcus cells; LC, lateral wall; SC, supporting cell; SPEC, spiral prominence epithelial cells; StE, strial endothelium; DFNA, the locus for autosomal dominant nonsyndromic deafness; DFNB, the locus for autosomal recessive nonsyndromic deafness

Development of the Mathematical Model of Cochlear K+ Transport

Multiple models describing EP generation and K⁺ transport have been proposed, originating from Davis’s battery theory, which conceptualized the cochlear lateral wall as a biological battery [27]. Early qualitative models, such as the two-pump and single-pump models (Fig. 5a), posited that marginal cells alone were sufficient to account for EP generation and K⁺ transport [26]. These models were developed at a time when the spatial distribution and functional roles of ion channels and transporters in the lateral wall were not yet fully elucidated. Subsequent identification of inwardly rectifying K⁺ channels, Kir4.1, in intermediate cells led to the development of the two-cell model (Fig. 5b), which attributes EP generation primarily to intermediate cells, whereas marginal cells are responsible for K⁺ secretion into the endolymph [4, 26, 72, 88, 99, 100, 108, 109]. Although the two-cell model provided a conceptual framework for understanding EP generation and K⁺ recycling (i.e., K⁺ circulation) under physiological conditions, it remained qualitative and lacked the capacity to predict EP dynamics under pharmacological or pathological perturbations.

Fig. 5.

Fig. 5

Models of the endocochlear potential and K+ transport in the cochlea. (a) Single cell models (the two-pump model and the single pump model) of EP. The EP is generated by an electrogenic K+-ATPase in the apical side of the marginal cell layer [26]. (b) The two-cell model of the EP generation. The cochlear lateral wall has two layers, which separate endolymph from the intrastrial space (IS) and IS from perilymph, respectively [100]. (c) Equivalent electrical circuit representing cochlear K+ transport (fibrocyte-integrating Nin-Hibino-Kurachi model: fi-NHK model) [78]. The circuit includes not only the lateral wall but also the hair cell layer. NKCC: Na+,K+,2Cl− co-transporter, ClC: Cl− channel, NSC: non-selective cation channel, MET channel: Mechanotransduction channel. The MET channel, located at the apex of the sensory hair cells, is an ion-permeable channel that opens in response to the bending of the hair cells due to sound stimuli. (d) The calculated dynamic changes in several electrochemical parameters under normal, anoxic, and Ba2+ block conditions. Orange and red lines indicate the ISP and EP, respectively. (e, f) illustrates the K+ concentration in the intrastrial space ([K+]IS) and marginal cells ([K+]MC), as well as the Cl− concentrations in the same locations ([Cl−]IS and [Cl−]MC). (g) Profiles of the circulation current in the lateral wall. Under physiological conditions, the circulation current is composed purely of K+ through Na+,K+-ATPases and NKCC1 in the basolateral surface of the marginal cell layer. Under anoxic conditions shown in right panel, the carrier of the circulation current switches from K+ to Cl− and Na+ that permeate the ClC and the non-selective cation channel (NSC), respectively. This change causes an increase in [K+]IS and [Cl−]IS and a decrease in [K+]MC and [Cl−]MC. (h) Difference between fi-NHK model and NHK model in the syncytium layer [77–79].

Adapted from references

Although our experimental findings have clarified the principal mechanisms underlying the generation of the EP under physiological conditions and its changes following transporter inhibition, two unresolved issues remain. The first concerns the reversal of K⁺ concentration gradients under hypoxic conditions, in which the K⁺ concentration in the IS markedly increases (Fig. 1c, second row). The second is the significant decline in K⁺ concentration within the syncytial layer upon inhibition of K⁺ transporters (Fig. 1c, third row)[76]. In most cell systems, inhibition of K⁺ transport would gradually lead to equilibration of intra- and extracellular K⁺ levels. However, a substantial decrease in extracellular K⁺, as observed here, is difficult to reconcile with conventional passive diffusion or equilibrium dynamics. These atypical responses cannot be adequately explained by standard models of ion homeostasis. To resolve these complexities and to integrate changes in electrical potential, ionic currents, and concentration dynamics across compartments, we adopted a computational modeling approach based on equivalent electrical circuitry [77].

As illustrated in Fig. 2b, the dynamics of membrane potential and transmembrane current—governed by ion channels—can be represented by an equivalent electrical circuit and expressed mathematically. Ion transporters, which regulate ion concentrations across membranes, can likewise be formulated within this framework. Accordingly, all membrane-bound transport molecules were incorporated into the circuit model. In this context, hair cells were conceptualized as light bulbs, the EP as a battery, and K⁺ transport as electric current. This framework constitutes a molecular-level mathematical model of cochlear K⁺ circulation (Fig. 5c), conceptually proposed by Davis and partially demonstrated by Brownell and colleagues [27, 119]. The magnitude of the K⁺ transport current is determined by the potential difference between the EP and the hair cell interior, which serves as the driving force for K⁺ influx through apical transduction cation channels of sensory hair cells. Therefore, a reduction in EP directly diminishes the electrochemical driving force, thereby decreasing K⁺ transport current.

Even in the absence of acoustic stimulation, a steady-state transduction current flows through cochlear hair cells [56, 57, 85, 108, 109]. This baseline condition was first modeled to define the resting distributions of membrane potentials, ionic concentrations, and ion fluxes across the cochlear lateral wall. Past experimental results have demonstrated a functional coupling between NKCC and Na⁺,K⁺-ATPase via local Na⁺ recycling, showing that inhibition of one transporter halts the transport activity of the other [76]. Therefore, hypoxic conditions were simulated by functionally inhibiting Na⁺,K⁺-ATPase and NKCC activity in the marginal cell layer [77]. The simulation accurately reproduced the experimentally observed changes in membrane potentials and K⁺ concentrations in both the cochlear lateral wall and the endolymph (Fig. 5d, e, and f) [76]. Our analysis revealed that upon inhibition of Na⁺,K⁺-ATPase and NKCC, the K⁺ currents normally mediated by these transporters were lost and replaced by inward Na⁺ and Cl⁻ currents via co-expressed cation and anion channels in marginal cells (Fig. 5g). Consequently, K⁺ influx into the IS continued unabated, whereas K⁺ efflux from marginal cells was halted, producing a reversal in K⁺ concentration gradients between the two compartments—an outcome consistent with the experimentally observed K⁺ inversion phenomenon (Fig. 1c).

Additionally, the mathematical model was refined to replicate the experimentally observed changes in K⁺ transport and membrane potential within the syncytial layer (Fig. 5h) [78]. Based on prior experimental evidence [1, 113, 114], K⁺ transport in the syncytium was modeled exclusively through Na⁺,K⁺-ATPase activity. This updated model successfully reproduced the outcomes of ouabain and bumetanide perfusion experiments applied via the perilymph (Fig. 4) [78].

Changes in the Ionic Environment of the Cochlear Lateral Wall and the EP During Sound Stimulation

Through the integrated theoretical and experimental approaches described above, the underlying ionic transport mechanisms responsible for the observed physiological phenomena have been elucidated with greater clarity. Consequently, mathematical modeling has proven to be an indispensable tool for interpreting results from animal experiments. However, the validity of theoretical predictions critically depends on empirical support; thus, continual refinement of simulations necessitates new in vivo experiments designed specifically to test and update model assumptions.

To investigate how K⁺ circulation is modulated under acoustic stimulation, we measured K⁺ concentration and electrical potential in the IS while applying varying sound pressures and frequencies. We observed that the IS potential decreased in response to increasing sound load, whereas K⁺ concentration increased (Fig. 6a and b) [116]. Notably, the K+ profile in the endolymph negligibly changed (Fig. 6a and c) [96]. The potential shift in the IS resembled previously reported changes in the EP; however, analogous fluctuations within the IS had not been documented prior to this study. These findings represent the first direct evidence that sound-induced hair cell currents functionally affect the ionic environment in the cochlear lateral wall. In addition, the measured dynamics of electrochemical properties were primarily replicated by our computational model, reinforcing the idea that the lateral wall is electrically connected to hair cells [116].

Fig. 6.

Fig. 6

Potential and K+ Concentration in IS and Endolymph during Sound Stimulation. (a) A series of in vivo electrophysiological recordings were performed on a guinea pig using a double-barreled microelectrode sensitive to both K⁺ concentration and potential. The microelectrode was advanced from the perilymph into the cochlear lateral wall and then retracted, with recordings obtained from the IS or endolymph. The red and blue lines represent potential and [K⁺], respectively. After passing through the outer syncytial layer, identified by an increase in K⁺ concentration and a low positive potential, the electrode was held in the IS. Anoxia caused a decrease in potential and an increase in K⁺ concentration. After returning to baseline, the animal was stimulated four times with a 1 kHz, 90 dB SPL tone-burst at 30 s intervals (orange bars). The electrode was then inserted into the endolymph, and the same acoustic stimulation protocol was applied. Expanded views of the recorded responses from the IS and endolymph (dotted boxes) are shown in (b) and (c), respectively. The filled wedge, open wedge, and gray bar above the trace denote periods of electrode advancement, retraction, and holding, respectively.

Adapted from a reference [116]

Physiological Significance of the Molecules Expressed in the Lateral Wall

Over the past three decades, extensive research has demonstrated that genetic disruption or mutation of ion transporters and structural proteins expressed in the cochlear lateral wall is closely associated with hearing loss in both humans and mouse models, as summarized in Table 1. For example, knockout of KCNE1 or KCNQ1 leads to collapse of the scala media, vestibular dysfunction, and ultimately profound deafness [15, 92, 105]. These findings underscore the critical role of KCNQ1/KCNE1 potassium channels in mediating K⁺ transport and maintaining the highly specialized ionic composition of the endolymph. In humans, mutations in either gene result in Jervell and Lange-Nielsen syndrome, a condition characterized by congenital sensorineural hearing loss and cardiac arrhythmias.

Similar pathological features—including collapse of the scala media and vestibular dysfunction—are observed in mice lacking NKCC1 [29, 31, 36]. Moreover, mutations in BSND, which encodes barttin, a subunit essential for Cl⁻ channel function [32], cause Type IV Bartter syndrome, characterized by renal salt wasting and sensorineural hearing loss. In corresponding knockout mice, EP is markedly reduced (~ + 17 mV) [9, 81]. Ablation of KCNJ10, which encodes the inwardly rectifying K⁺ channel Kir4.1, induces structural disorganization of the cochlea and a near-complete loss of EP [10, 73, 84, 89]. In humans, mutations in KCNJ10 result in EAST/SeSAME syndrome, presenting as a constellation of deafness, epilepsy, ataxia, and renal tubulopathy. Similarly, the two-pore domain K⁺ channel KCNK5, predominantly expressed in outer sulcus cells (OSCs), is critical for cochlear function; its deletion results in degeneration of hair cells and spiral ganglion neurons, along with partial EP loss (~ + 50 mV) [16].

Recent studies have identified additional molecular determinants essential for maintaining cochlear lateral wall integrity [104]. Although KCNJ16, which is localized to the spiral ligament (SL) and supporting cells (SC), appears to be dispensable for normal auditory function [71], disruption of ZBTB20, a gene expressed in outer sulcus cells (OSCs), impairs root cell differentiation and results in hearing loss [112]. Mutations in SLC26A4, which encodes pendrin, are responsible for Pendred syndrome and DFNB4, both characterized by sensorineural hearing loss and thyroid dysfunction [2, 34, 35, 110]. Pendrin-deficient mice exhibit EP collapse (~ 0 mV), cochlear malfunction, and vestibular defects; however, recent gene therapy approaches have successfully restored both EP and auditory function in experimental models [23, 33, 46, 51, 58, 83, 91].

Other notable genes affecting cochlear function include SLC22A4, linked to DFNB60-associated deafness [6], and SLC12A6 (KCC3), whose deletion leads to hair cell degeneration [11]. Loss of hepatocyte growth factor (HGF) results in DFNB39, characterized by impaired migration of neural crest–derived cells and a concomitant reduction in EP [74]. Mutations in CHD7, a gene implicated in the formation of enlarged vestibular aqueducts, cause structural abnormalities in the lateral wall and lead to hearing loss [82]. Gap junction proteins are also essential for cochlear homeostasis. Deficiencies in connexins such as Cx26 (GJB2), Cx30 (GJB6), or Cx43 (GJA1) cause reductions in EP and progressive hair cell degeneration, ultimately resulting in hearing impairment [7, 8, 20, 21, 28, 30, 37, 39, 52, 54, 55, 67, 70, 90, 97, 103, 115, 117, 118]. Mutations in Cx31 (GJB3) and Cx32 (GJB1) further underscore the importance of the connexin network, being associated with nonsyndromic hearing loss and X-linked Charcot–Marie–Tooth disease, respectively [95, 111]. Ablation of pannexin-1 (Panx1), expressed in fibrocytes and OSCs, significantly reduces EP (~ + 60 mV), highlighting the role of purinergic signaling in cochlear ion homeostasis [18]. Similarly, disruption of claudin-11, a tight junction protein, impairs EP (~ + 30 mV), emphasizing the necessity of barrier integrity within basal cells of the stria vascularis [38, 59, 60, 69]. In addition, the lack of detectable ATP1A1 and ATP1B1 expression in the human syncytial layer contrasts with functional models derived largely from rodent studies [68]. This discrepancy may reflect species-specific differences or the contribution of alternative Na⁺/K⁺-ATPase isoforms, such as ATP1A2 or ATP1B2, in the human cochlear lateral wall, an issue that remains to be clarified.

Collectively, these findings underscore the multifactorial contributions of ion transport mechanisms, gap junction–mediated intercellular communication, and epithelial barrier integrity to the maintenance of cochlear homeostasis and normal auditory function.

Further Questions, Prospects, and Conclusion

In summary, the intricate interdependence between cochlear K⁺ circulation driven by K⁺ transport and the generation of the EP has been elucidated through a combination of in vivo electrophysiological investigations and quantitative mathematical modeling. Although numerous molecular constituents critical for EP formation and K⁺ homeostasis have been identified, their precise functional contributions and spatial localization within the cochlea remain incompletely characterized.

Future studies should aim to integrate these molecular roles into comprehensive quantitative models to more precisely delineate their contributions to cochlear physiology. From a fundamental biomedical perspective, several key questions remain unresolved—for example, the mechanisms underlying the spatial heterogeneity of EP along the cochlear spiral, and whether the lateral wall exhibits region-specific specializations aligned with frequency tuning. Addressing these challenges will require the development of novel theoretical frameworks capable of capturing phenomena that remain unexplained by current models, through the integration of both established and emerging experimental and computational approaches. Furthermore, the strial vascular system plays an essential supporting role by maintaining metabolic homeostasis and providing the energetic conditions required for sustained ion transport. Disruption of blood flow or oxygen supply is known to cause a rapid decline in EP, indicating that vascular integrity is indispensable for preserving the electrochemical environment of the cochlear lateral wall. Recent genetic and pathological studies further suggest that vascular dysfunction can indirectly compromise EP maintenance. In particular, variants in S1PR2, a receptor with well-established roles in vascular stability and endothelial signaling, are associated with a progressive decline in EP in mice and hearing impairment in humans [49]. In addition, analyses of Norrie disease patients and corresponding animal models demonstrate that abnormalities in cochlear microvasculature precede EP decline and sensory dysfunction [14]. These findings support a model in which vascular pathology acts as a modulatory factor that can secondarily impair EP by disrupting metabolic and ionic balance.

From a clinical otolaryngological perspective, decades of electrophysiological analyses on the inner ear have yielded critical insights into the mechanisms sustaining the EP as an emergent organ-level function. However, these advances have yet to be translated into clinical applications. This translational gap likely stems from the lack of a unifying conceptual framework that bridges molecular mechanisms with whole-organ function.

The integrative strategy proposed in our works—merging experimental and computational methodologies—offers a promising avenue for elucidating organ-level physiological processes in terms of underlying molecular dynamics, thereby providing a theoretical foundation for systems-level interpretation. A comprehensive, mechanistic understanding of normal cochlear function will ultimately facilitate more refined insights into the pathogenesis of auditory disorders and support the development of novel, mechanism-based therapeutic interventions.

Acknowledgements

We thank the late Professor A. J. Hudspeth for his lasting intellectual influence.

Author Contributions

F.N. and H. H. conceived the scope and structure of the review. F.N. and H. H. wrote the original draft. F.N. and H. H. reviewed, edited, and approved the final manuscript.

Funding

Open Access funding provided by Gifu University. This work was partially supported by the following research grants and funds: Grants-in-Aid for Scientific Research (B) 24K02598 (to F.N.), Grants-in-Aid for Scientific Research (A) 24H00798 (to H.H.), AMED-CREST (Multi-sensing: 25gm1510004 and Mechanobiology: 20gm08100004) (to H.H.).

Declarations

Use of AI-Assisted Technologies

During the preparation of this manuscript, the authors used OpenAI ChatGPT (GPT-5.2, OpenAI, San Francisco, CA, USA; used in 2026) solely for assistance with English grammar, clarity, and stylistic refinement of the text. The AI tool did not generate or modify any scientific content, data, analyses, or interpretations. The authors take full responsibility for the integrity and accuracy of the manuscript.

Conflict of interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

Fumiaki Nin, Email: nin.fumiaki.u7@f.gifu-u.ac.jp.

Hiroshi Hibino, Email: hibino@pharma2.med.osaka-u.ac.jp.

References

  • 1.Adachi N, Yoshida T, Nin F, Ogata G, Yamaguchi S, Suzuki T, Komune S, Hisa Y, Hibino H, Kurachi Y (2013) The mechanism underlying maintenance of the endocochlear potential by the K+ transport system in fibrocytes of the inner ear. J Physiol 591(18):4459–4472. 10.1113/jphysiol.2013.258046 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Albert S, Blons H, Jonard L, Feldmann D, Chauvin P, Loundon N, Sergent-Allaoui A, Houang M, Joannard A, Schmerber S, Delobel B, Leman J, Journel H, Catros H, Dollfus H, Eliot MM, David A, Calais C, Drouin-Garraud V, Obstoy MF, Tran Ba Huy P, Lacombe D, Duriez F, Francannet C, Bitoun P, Petit C, Garabedian EN, Couderc R, Marlin S, Denoyelle F (2006) SLC26A4 gene is frequently involved in nonsyndromic hearing impairment with enlarged vestibular aqueduct in Caucasian populations. Eur J Hum Genet 14(6):773–779. 10.1038/sj.ejhg.5201611 [DOI] [PubMed] [Google Scholar]
  • 3.Alberts BJ, Lewis A, Raff J, Roberts M, Walter K (2014) Molecular biology of the cell, 5th edn. New York: Newton Press [Google Scholar]
  • 4.Ando M, Takeuchi S (1999) Immunological identification of an inward rectifier K+ channel (Kir4.1) in the intermediate cell (melanocyte) of the cochlear stria vascularis of gerbils and rats. Cell Tissue Res 298(1):179–183 [DOI] [PubMed] [Google Scholar]
  • 5.Bekesy G (1952) Dc resting potentials inside the cochlear partition. J Acoust Soc Am 24(1):72–76 [Google Scholar]
  • 6.Ben Said M, Grati M, Ishimoto T, Zou B, Chakchouk I, Ma Q, Yao Q, Hammami B, Yan D, Mittal R, Nakamichi N, Ghorbel A, Neng L, Tekin M, Shi XR, Kato Y, Masmoudi S, Lu Z, Hmani M, Liu X (2016) A mutation in SLC22A4 encoding an organic cation transporter expressed in the cochlea strial endothelium causes human recessive non-syndromic hearing loss DFNB60. Hum Genet 135(5):513–524. 10.1007/s00439-016-1657-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Berger AC, Kelly JJ, Lajoie P, Shao Q, Laird DW (2014) Mutations in Cx30 that are linked to skin disease and non-syndromic hearing loss exhibit several distinct cellular pathologies. J Cell Sci 127(Pt 8):1751–1764. 10.1242/jcs.138230 [DOI] [PubMed] [Google Scholar]
  • 8.Bicego M, Beltramello M, Melchionda S, Carella M, Piazza V, Zelante L, Bukauskas FF, Arslan E, Cama E, Pantano S, Bruzzone R, D’Andrea P, Mammano F (2006) Pathogenetic role of the deafness-related M34T mutation of Cx26. Hum Mol Genet 15(17):2569–2587. 10.1093/hmg/ddl184 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Birkenhager R, Otto E, Schurmann MJ, Vollmer M, Ruf EM, Maier-Lutz I, Beekmann F, Fekete A, Omran H, Feldmann D, Milford DV, Jeck N, Konrad M, Landau D, Knoers NV, Antignac C, Sudbrak R, Kispert A, Hildebrandt F (2001) Mutation of BSND causes Bartter syndrome with sensorineural deafness and kidney failure. Nat Genet 29(3):310–314. 10.1038/ng752 [DOI] [PubMed] [Google Scholar]
  • 10.Bockenhauer D, Feather S, Stanescu HC, Bandulik S, Zdebik AA, Reichold M, Tobin J, Lieberer E, Sterner C, Landoure G, Arora R, Sirimanna T, Thompson D, Cross JH, van’t Hoff W, Al Masri O, Tullus K, Yeung S, Anikster Y, Klootwijk E, Hubank M, Dillon MJ, Heitzmann D, Arcos-Burgos M, Knepper MA, Dobbie A, Gahl WA, Warth R, Sheridan E, Kleta R (2009) Epilepsy, ataxia, sensorineural deafness, tubulopathy, and KCNJ10 mutations. N Engl J Med 360(19):1960–1970. 10.1056/NEJMoa0810276 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Boettger T, Rust MB, Maier H, Seidenbecher T, Schweizer M, Keating DJ, Faulhaber J, Ehmke H, Pfeffer C, Scheel O, Lemcke B, Horst J, Leuwer R, Pape HC, Volkl H, Hubner CA, Jentsch TJ (2003) Loss of K-Cl co-transporter KCC3 causes deafness, neurodegeneration and reduced seizure threshold. EMBO J 22(20):5422–5434. 10.1093/emboj/cdg519 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Bok D, Galbraith G, Lopez I, Woodruff M, Nusinowitz S, BeltrandelRio H, Huang W, Zhao S, Geske R, Montgomery C, Van Sligtenhorst I, Friddle C, Platt K, Sparks MJ, Pushkin A, Abuladze N, Ishiyama A, Dukkipati R, Liu W, Kurtz I (2003) Blindness and auditory impairment caused by loss of the sodium bicarbonate cotransporter NBC3. Nat Genet 34(3):313–319. 10.1038/ng1176 [DOI] [PubMed] [Google Scholar]
  • 13.Boron WF, Chen L, Parker MD (2009) Modular structure of sodium-coupled bicarbonate transporters. J Exp Biol 212(Pt 11):1697–1706. 10.1242/jeb.028563 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Bryant D, Pauzuolyte V, Ingham NJ, Patel A, Pagarkar W, Anderson LA, Smith KE, Moulding DA, Leong YC, Jafree DJ, Long DA, Al-Yassin A, Steel KP, Jagger DJ, Forge A, Berger W, Sowden JC, Bitner-Glindzicz M (2022) The timing of auditory sensory deficits in Norrie disease has implications for therapeutic intervention. JCI Insight. 10.1172/jci.insight.148586 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Casimiro MC, Knollmann BC, Ebert SN, Vary JC Jr., Greene AE, Franz MR, Grinberg A, Huang SP, Pfeifer K (2001) Targeted disruption of the Kcnq1 gene produces a mouse model of Jervell and Lange-Nielsen Syndrome. Proc Natl Acad Sci U S A 98(5):2526–2531. 10.1073/pnas.041398998 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Cazals Y, Bevengut M, Zanella S, Brocard F, Barhanin J, Gestreau C (2015) KCNK5 channels mostly expressed in cochlear outer sulcus cells are indispensable for hearing. Nat Commun 6:8780. 10.1038/ncomms9780 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Chan DK, Hudspeth AJ (2005) Ca2+ current-driven nonlinear amplification by the mammalian cochlea in vitro. Nat Neurosci 8(2):149–155. 10.1038/nn1385 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Chen J, Zhu Y, Liang C, Chen J, Zhao HB (2015) Pannexin1 channels dominate ATP release in the cochlea ensuring endocochlear potential and auditory receptor potential generation and hearing. Sci Rep 5:10762. 10.1038/srep10762 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Choi I, Aalkjaer C, Boulpaep EL, Boron WF (2000) An electroneutral sodium/bicarbonate cotransporter NBCn1 and associated sodium channel. Nature 405(6786):571–575. 10.1038/35014615 [DOI] [PubMed] [Google Scholar]
  • 20.Cohen-Salmon M, Ott T, Michel V, Hardelin JP, Perfettini I, Eybalin M, Wu T, Marcus DC, Wangemann P, Willecke K, Petit C (2002) Targeted ablation of connexin26 in the inner ear epithelial gap junction network causes hearing impairment and cell death. Curr Biol 12(13):1106–1111 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Cohen-Salmon M, Regnault B, Cayet N, Caille D, Demuth K, Hardelin JP, Janel N, Meda P, Petit C (2007) Connexin30 deficiency causes instrastrial fluid-blood barrier disruption within the cochlear stria vascularis. Proc Natl Acad Sci USA 104(15):6229–6234. 10.1073/pnas.0605108104 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Corey DP, Hudspeth AJ (1983) Kinetics of the receptor current in bullfrog saccular hair cells. J Neurosci 3(5):962–976. 10.1523/JNEUROSCI.03-05-00962.1983 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Cremers WR, Bolder C, Admiraal RJ, Everett LA, Joosten FB, van Hauwe P, Green ED, Otten BJ (1998) Progressive sensorineural hearing loss and a widened vestibular aqueduct in Pendred syndrome. Arch Otolaryngol Head Neck Surg 124(5):501–505 [DOI] [PubMed] [Google Scholar]
  • 24.Crouch JJ, Sakaguchi N, Lytle C, Schulte BA (1997) Immunohistochemical localization of the Na-K-Cl co-transporter (NKCC1) in the gerbil inner ear. J Histochem Cytochem 45(6):773–778 [DOI] [PubMed] [Google Scholar]
  • 25.Dacey DM, Packer OS (2003) Colour coding in the primate retina: diverse cell types and cone-specific circuitry. Curr Opin Neurobiol 13(4):421–427. 10.1016/s0959-4388(03)00103-x [DOI] [PubMed] [Google Scholar]
  • 26.Dallos P, Popper NA, Fay RR (1996) The cochlea. New York: Springer-Verlag [Google Scholar]
  • 27.Davis H (1961) Some principles of sensory receptor action. Physiol Rev 41:391–416 [DOI] [PubMed] [Google Scholar]
  • 28.del Castillo I, Villamar M, Moreno-Pelayo MA, del Castillo FJ, Alvarez A, Telleria D, Menendez I, Moreno F (2002) A deletion involving the connexin 30 gene in nonsyndromic hearing impairment. N Engl J Med 346(4):243–249. 10.1056/NEJMoa012052 [DOI] [PubMed] [Google Scholar]
  • 29.Delpire E, Lu J, England R, Dull C, Thorne T (1999) Deafness and imbalance associated with inactivation of the secretory Na-K-2Cl co-transporter. Nat Genet 22(2):192–195. 10.1038/9713 [DOI] [PubMed] [Google Scholar]
  • 30.Denoyelle F, Weil D, Maw MA, Wilcox SA, Lench NJ, Allen-Powell DR, Osborn AH, Dahl HH, Middleton A, Houseman MJ, Dode C, Marlin S, Boulila-ElGaied A, Grati M, Ayadi H, BenArab S, Bitoun P, Lina-Granade G, Godet J, Mustapha M, Loiselet J, El-Zir E, Aubois A, Joannard A, Levilliers J, Garabedian EN, Mueller RF, Gardner RJ, Petit C et al (1997) Prelingual deafness: high prevalence of a 30delG mutation in the connexin 26 gene. Hum Mol Genet 6(12):2173–2177 [DOI] [PubMed] [Google Scholar]
  • 31.Dixon MJ, Gazzard J, Chaudhry SS, Sampson N, Schulte BA, Steel KP (1999) Mutation of the Na-K-Cl co-transporter gene Slc12a2 results in deafness in mice. Hum Mol Genet 8(8):1579–1584 [DOI] [PubMed] [Google Scholar]
  • 32.Estevez R, Boettger T, Stein V, Birkenhager R, Otto E, Hildebrandt F, Jentsch TJ (2001) Barttin is a Cl- channel beta-subunit crucial for renal Cl- reabsorption and inner ear K+ secretion. Nature 414(6863):558–561. 10.1038/35107099 [DOI] [PubMed] [Google Scholar]
  • 33.Everett LA, Belyantseva IA, Noben-Trauth K, Cantos R, Chen A, Thakkar SI, Hoogstraten-Miller SL, Kachar B, Wu DK, Green ED (2001) Targeted disruption of mouse PDS provides insight about the inner-ear defects encountered in Pendred syndrome. Hum Mol Genet 10(2):153–161 [DOI] [PubMed] [Google Scholar]
  • 34.Everett LA, Glaser B, Beck JC, Idol JR, Buchs A, Heyman M, Adawi F, Hazani E, Nassir E, Baxevanis AD, Sheffield VC, Green ED (1997) Pendred syndrome is caused by mutations in a putative sulphate transporter gene (PDS). Nat Genet 17(4):411–422. 10.1038/ng1297-411 [DOI] [PubMed] [Google Scholar]
  • 35.Everett LA, Morsli H, Wu DK, Green ED (1999) Expression pattern of the mouse ortholog of the Pendred’s syndrome gene (Pds) suggests a key role for pendrin in the inner ear. Proc Natl Acad Sci U S A 96(17):9727–9732 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Flagella M, Clarke LL, Miller ML, Erway LC, Giannella RA, Andringa A, Gawenis LR, Kramer J, Duffy JJ, Doetschman T, Lorenz JN, Yamoah EN, Cardell EL, Shull GE (1999) Mice lacking the basolateral Na-K-2Cl cotransporter have impaired epithelial chloride secretion and are profoundly deaf. J Biol Chem 274(38):26946–26955 [DOI] [PubMed] [Google Scholar]
  • 37.Gerido DA, DeRosa AM, Richard G, White TW (2007) Aberrant hemichannel properties of Cx26 mutations causing skin disease and deafness. Am J Physiol Cell Physiol 293(1):C337-345. 10.1152/ajpcell.00626.2006 [DOI] [PubMed] [Google Scholar]
  • 38.Gow A, Davies C, Southwood CM, Frolenkov G, Chrustowski M, Ng L, Yamauchi D, Marcus DC, Kachar B (2004) Deafness in Claudin 11-null mice reveals the critical contribution of basal cell tight junctions to stria vascularis function. J Neurosci 24(32):7051–7062. 10.1523/JNEUROSCI.1640-04.2004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Grifa A, Wagner CA, D’Ambrosio L, Melchionda S, Bernardi F, Lopez-Bigas N, Rabionet R, Arbones M, Monica MD, Estivill X, Zelante L, Lang F, Gasparini P (1999) Mutations in GJB6 cause nonsyndromic autosomal dominant deafness at DFNA3 locus. Nat Genet 23(1):16–18 [DOI] [PubMed] [Google Scholar]
  • 40.Groger N, Frohlich H, Maier H, Olbrich A, Kostin S, Braun T, Boettger T (2010) SLC4A11 prevents osmotic imbalance leading to corneal endothelial dystrophy, deafness, and polyuria. J Biol Chem 285(19):14467–14474. 10.1074/jbc.M109.094680 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Hibino H, Horio Y, Inanobe A, Doi K, Ito M, Yamada M, Gotow T, Uchiyama Y, Kawamura M, Kubo T, Kurachi Y (1997) An ATP-dependent inwardly rectifying potassium channel, KAB-2 (Kir4. 1), in cochlear stria vascularis of inner ear: its specific subcellular localization and correlation with the formation of endocochlear potential. J Neurosci 17(12):4711–4721 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Hibino H, Kurachi Y (2006) Molecular and physiological bases of the K+ circulation in the mammalian inner ear. Physiology (Bethesda) 21:336–345. 10.1152/physiol.00023.2006 [DOI] [PubMed] [Google Scholar]
  • 43.Hibino H, Nin F, Tsuzuki C, Kurachi Y (2010) How is the highly positive endocochlear potential formed? The specific architecture of the stria vascularis and the roles of the ion-transport apparatus. Pflugers Arch 459(4):521–533. 10.1007/s00424-009-0754-z [DOI] [PubMed] [Google Scholar]
  • 44.Hinojosa R, Rodriguez-Echandia EL (1966) The fine structure of the stria vascularis of the cat inner ear. Am J Anat 118(2):631–663. 10.1002/aja.1001180218 [DOI] [PubMed] [Google Scholar]
  • 45.Honrubia V, Ward PH (1969) Dependence of the cochlear microphonics and the summating potential on the endocochlear potential. J Acoust Soc Am 46(2):388–392 [DOI] [PubMed] [Google Scholar]
  • 46.Huang CY, Tsai YH, Cheng YF, Wu PY, Chuang YC, Huang PY, Liu JS, Wu CC, Cheng YF (2024) CRISPR/Cas9-mediated exon skipping to restore premature translation termination in a DFNB4 mouse model. Gene Ther 31(11–12):531–540. 10.1038/s41434-024-00483-9 [DOI] [PubMed] [Google Scholar]
  • 47.Hudspeth AJ (1989) How the ear’s works work. Nature 341(6241):397–404. 10.1038/341397a0 [DOI] [PubMed] [Google Scholar]
  • 48.Ikeda K, Morizono T (1989) Electrochemical profile for calcium ions in the stria vascularis: cellular model of calcium transport mechanism. Hear Res 40(1–2):111–116 [DOI] [PubMed] [Google Scholar]
  • 49.Ingham NJ, Carlisle F, Pearson S, Lewis MA, Buniello A, Chen J, Isaacson RL, Pass J, White JK, Dawson SJ, Steel KP (2016) S1PR2 variants associated with auditory function in humans and endocochlear potential decline in mouse. Sci Rep 6:28964. 10.1038/srep28964 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Jacob S, Pienkowski M, Fridberger A (2011) The endocochlear potential alters cochlear micromechanics. Biophys J 100(11):2586–2594. 10.1016/j.bpj.2011.05.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Johnsen T, Larsen C, Friis J, Hougaard-Jensen F (1987) Pendred’s syndrome. Acoustic, vestibular and radiological findings in 17 unrelated patients. J Laryngol Otol 101(11):1187–1192 [DOI] [PubMed] [Google Scholar]
  • 52.Kamiya K, Yum SW, Kurebayashi N, Muraki M, Ogawa K, Karasawa K, Miwa A, Guo X, Gotoh S, Sugitani Y, Yamanaka H, Ito-Kawashima S, Iizuka T, Sakurai T, Noda T, Minowa O, Ikeda K (2014) Assembly of the cochlear gap junction macromolecular complex requires connexin 26. J Clin Invest 124(4):1598–1607. 10.1172/JCI67621 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Kandel RE, Schwarts HJ, Jessell MT, Siegelbaum AS, Hudspeth AJ (2013) Principles of neural science. New York: McGraw-Hill [Google Scholar]
  • 54.Kelley PM, Abe S, Askew JW, Smith SD, Usami S, Kimberling WJ (1999) Human connexin 30 (GJB6), a candidate gene for nonsyndromic hearing loss: molecular cloning, tissue-specific expression, and assignment to chromosome 13q12. Genomics 62(2):172–176. 10.1006/geno.1999.6002 [DOI] [PubMed] [Google Scholar]
  • 55.Kelsell DP, Dunlop J, Stevens HP, Lench NJ, Liang JN, Parry G, Mueller RF, Leigh IM (1997) Connexin 26 mutations in hereditary non-syndromic sensorineural deafness. Nature 387(6628):80–83. 10.1038/387080a0 [DOI] [PubMed] [Google Scholar]
  • 56.Kikuchi T, Adams JC, Miyabe Y, So E, Kobayashi T (2000) Potassium ion recycling pathway via gap junction systems in the mammalian cochlea and its interruption in hereditary nonsyndromic deafness. Med Electron Microsc 33(2):51–56. 10.1007/s007950000009 [DOI] [PubMed] [Google Scholar]
  • 57.Kikuchi T, Kimura RS, Paul DL, Adams JC (1995) Gap junctions in the rat cochlea: immunohistochemical and ultrastructural analysis. Anat Embryol (Berl) 191(2):101–118 [DOI] [PubMed] [Google Scholar]
  • 58.Kim MA, Kim SH, Ryu N, Ma JH, Kim YR, Jung J, Hsu CJ, Choi JY, Lee KY, Wangemann P, Bok J, Kim UK (2019) Gene therapy for hereditary hearing loss by SLC26A4 mutations in mice reveals distinct functional roles of pendrin in normal hearing. Theranostics 9(24):7184–7199. 10.7150/thno.38032 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Kitajiri S, Miyamoto T, Mineharu A, Sonoda N, Furuse K, Hata M, Sasaki H, Mori Y, Kubota T, Ito J, Furuse M, Tsukita S (2004) Compartmentalization established by claudin-11-based tight junctions in stria vascularis is required for hearing through generation of endocochlear potential. J Cell Sci 117(Pt 21):5087–5096. 10.1242/jcs.01393 [DOI] [PubMed] [Google Scholar]
  • 60.Kitajiri SI, Furuse M, Morita K, Saishin-Kiuchi Y, Kido H, Ito J, Tsukita S (2004) Expression patterns of claudins, tight junction adhesion molecules, in the inner ear. Hear Res 187(1–2):25–34 [DOI] [PubMed] [Google Scholar]
  • 61.Konishi T, Batler AR, Cesar F (1961) Effect of anoxia on cochlear potentials. J Acoust Soc Am 33(3):349–356
  • 62.Konishi T, Hamrick PE, Walsh PJ (1978) Ion transport in guinea pig cochlea. I. Potassium and sodium transport. Acta Otolaryngol 86(1–2):22–34 [DOI] [PubMed] [Google Scholar]
  • 63.Kuijpers W, Bonting SL (1970) The cochlear potentials. I. The effect of ouabain on the cochlear potentials of the guinea pig. Pflugers Arch 320(4):348–358 [DOI] [PubMed] [Google Scholar]
  • 64.Kuijpers W, Bonting SL (1970) The cochlear potentials. II. The nature of the cochlear endolymphatic resting potential. Pflugers Arch 320(4):359–372 [DOI] [PubMed] [Google Scholar]
  • 65.Kumar NM, Gilula NB (1996) The gap junction communication channel. Cell 84(3):381–388 [DOI] [PubMed] [Google Scholar]
  • 66.Kusakari J, Rokugo M, Kambayashi J, Arakawa E, Ohyama K, Hara A, Kawamoto K (1983) Generation mechanism of the negative endocochlear potential during early stage of anoxia. ORL J Otorhinolaryngol Relat Spec 45(4):195–202 [DOI] [PubMed] [Google Scholar]
  • 67.Lautermann J, ten Cate WJ, Altenhoff P, Grummer R, Traub O, Frank H, Jahnke K, Winterhager E (1998) Expression of the gap-junction connexins 26 and 30 in the rat cochlea. Cell Tissue Res 294(3):415–420 [DOI] [PubMed] [Google Scholar]
  • 68.Liu W, Rask-Andersen H (2022) Na/K-ATPase gene expression in the human cochlea: a study using mRNA in situ hybridization and super-resolution structured illumination microscopy. Front Mol Neurosci 15:857216. 10.3389/fnmol.2022.857216 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Liu W, Schrott-Fischer A, Glueckert R, Benav H, Rask-Andersen H (2017) The human “cochlear battery” - claudin-11 barrier and ion transport proteins in the lateral wall of the cochlea. Front Mol Neurosci 10:239. 10.3389/fnmol.2017.00239 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Liu XZ, Xia XJ, Adams J, Chen ZY, Welch KO, Tekin M, Ouyang XM, Kristiansen A, Pandya A, Balkany T, Arnos KS, Nance WE (2001) Mutations in GJA1 (connexin 43) are associated with non-syndromic autosomal recessive deafness. Hum Mol Genet 10(25):2945–2951 [DOI] [PubMed] [Google Scholar]
  • 71.Lv J, Fu X, Li Y, Hong G, Li P, Lin J, Xun Y, Fang L, Weng W, Yue R, Li GL, Guan B, Li H, Huang Y, Chai R (2021) Deletion of Kcnj16 in mice does not alter auditory function. Front Cell Dev Biol 9:630361. 10.3389/fcell.2021.630361 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Marcus DC, Rokugo M, Thalmann R (1985) Effects of barium and ion substitutions in artificial blood on endocochlear potential. Hear Res 17(1):79–86 [DOI] [PubMed] [Google Scholar]
  • 73.Marcus DC, Wu T, Wangemann P, Kofuji P (2002) KCNJ10 (Kir4.1) potassium channel knockout abolishes endocochlear potential. Am J Physiol Cell Physiol 282(2):C403–C407. 10.1152/ajpcell.00312.2001 [DOI] [PubMed] [Google Scholar]
  • 74.Morell RJ, Olszewski R, Tona R, Leitess S, Wafa TT, Taukulis I, Schultz JM, Thomason EJ, Richards K, Whitley BN, Hill C, Saunders T, Starost MF, Fitzgerald T, Wilson E, Ohyama T, Friedman TB, Hoa M (2020) Noncoding microdeletion in mouse Hgf disrupts neural crest migration into the stria vascularis, reduces the endocochlear potential, and suggests the neuropathology for human nonsyndromic deafness DFNB39. J Neurosci 40(15):2976–2992. 10.1523/JNEUROSCI.2278-19.2020 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Nakazawa K, Spicer SS, Schulte BA (1995) Ultrastructural localization of Na,K-ATPase in the gerbil cochlea. J Histochem Cytochem 43(10):981–991 [DOI] [PubMed] [Google Scholar]
  • 76.Nin F, Hibino H, Doi K, Suzuki T, Hisa Y, Kurachi Y (2008) The endocochlear potential depends on two K+ diffusion potentials and an electrical barrier in the stria vascularis of the inner ear. Proc Natl Acad Sci U S A 105(5):1751–1756. 10.1073/pnas.0711463105 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Nin F, Hibino H, Murakami S, Suzuki T, Hisa Y, Kurachi Y (2012) Computational model of a circulation current that controls electrochemical properties in the mammalian cochlea. Proc Natl Acad Sci U S A 109(23):9191–9196. 10.1073/pnas.1120067109 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Nin F, Yoshida T, Murakami S, Ogata G, Uetsuka S, Choi S, Doi K, Sawamura S, Inohara H, Komune S, Kurachi Y, Hibino H (2017) Computer modeling defines the system driving a constant current crucial for homeostasis in the mammalian cochlea by integrating unique ion transports. NPJ Syst Biol Appl 3:24. 10.1038/s41540-017-0025-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Nin F, Yoshida T, Sawamura S, Ogata G, Ota T, Higuchi T, Murakami S, Doi K, Kurachi Y, Hibino H (2016) The unique electrical properties in an extracellular fluid of the mammalian cochlea; their functional roles, homeostatic processes, and pathological significance. Pflugers Arch 468(10):1637–1649. 10.1007/s00424-016-1871-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Osborn A, Caruana D, Furness DN, Evans MG (2022) Electrical and immunohistochemical properties of cochlear fibrocytes in 3D cell culture and in the excised spiral ligament of mice. J Assoc Res Otolaryngol 23(2):183–193. 10.1007/s10162-021-00833-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Rickheit G, Maier H, Strenzke N, Andreescu CE, De Zeeuw CI, Muenscher A, Zdebik AA, Jentsch TJ (2008) Endocochlear potential depends on Cl- channels: mechanism underlying deafness in Bartter syndrome IV. EMBO J 27(21):2907–2917. 10.1038/emboj.2008.203 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Roux I, Fenollar-Ferrer C, Lee HJ, Chattaraj P, Lopez IA, Han K, Honda K, Brewer CC, Butman JA, Morell RJ, Martin DM, Griffith AJ (2023) CHD7 variants associated with hearing loss and enlargement of the vestibular aqueduct. Hum Genet 142(10):1499–1517. 10.1007/s00439-023-02581-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Royaux IE, Belyantseva IA, Wu T, Kachar B, Everett LA, Marcus DC, Green ED (2003) Localization and functional studies of pendrin in the mouse inner ear provide insight about the etiology of deafness in pendred syndrome. J Assoc Res Otolaryngol 4(3):394–404 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Rozengurt N, Lopez I, Chiu CS, Kofuji P, Lester HA, Neusch C (2003) Time course of inner ear degeneration and deafness in mice lacking the Kir4.1 potassium channel subunit. Hear Res 177(1–2):71–80 [DOI] [PubMed] [Google Scholar]
  • 85.Russell IJ, Cody AR, Richardson GP (1986) The responses of inner and outer hair cells in the basal turn of the guinea-pig cochlea and in the mouse cochlea grown in vitro. Hear Res 22:199–216 [DOI] [PubMed] [Google Scholar]
  • 86.Ryan AF, Watts AG (1991) Expression of mRNAs encoding alpha and beta subunit isoforms of the Na,K-ATPase in the rat cochlea. Mol Cell Neurosci 2(2):179–187 [DOI] [PubMed] [Google Scholar]
  • 87.Sakagami M, Fukazawa K, Matsunaga T, Fujita H, Mori N, Takumi T, Ohkubo H, Nakanishi S (1991) Cellular localization of rat Isk protein in the stria vascularis by immunohistochemical observation. Hear Res 56(1–2):168–172 [DOI] [PubMed] [Google Scholar]
  • 88.Salt AN, Melichar I, Thalmann R (1987) Mechanisms of endocochlear potential generation by stria vascularis. Laryngoscope 97(8 Pt 1):984–991 [PubMed] [Google Scholar]
  • 89.Scholl UI, Choi M, Liu T, Ramaekers VT, Hausler MG, Grimmer J, Tobe SW, Farhi A, Nelson-Williams C, Lifton RP (2009) Seizures, sensorineural deafness, ataxia, mental retardation, and electrolyte imbalance (SeSAME syndrome) caused by mutations in KCNJ10. Proc Natl Acad Sci USA 106(14):5842–5847. 10.1073/pnas.0901749106 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90.Schutz M, Auth T, Gehrt A, Bosen F, Korber I, Strenzke N, Moser T, Willecke K (2011) The connexin26 S17F mouse mutant represents a model for the human hereditary keratitis-ichthyosis-deafness syndrome. Hum Mol Genet 20(1):28–39. 10.1093/hmg/ddq429 [DOI] [PubMed] [Google Scholar]
  • 91.Sheffield VC, Kraiem Z, Beck JC, Nishimura D, Stone EM, Salameh M, Sadeh O, Glaser B (1996) Pendred syndrome maps to chromosome 7q21-34 and is caused by an intrinsic defect in thyroid iodine organification. Nat Genet 12(4):424–426. 10.1038/ng0496-424 [DOI] [PubMed] [Google Scholar]
  • 92.Shen Z, Marcus DC (1998) Divalent cations inhibit IsK/KvLQT1 channels in excised membrane patches of strial marginal cells. Hear Res 123(1–2):157–167. 10.1016/s0378-5955(98)00110-5 [DOI] [PubMed] [Google Scholar]
  • 93.Smith CA, Lowry OH, Wu ML (1954) The electrolytes of the labyrinthine fluids. Laryngoscope 64(3):141–153. 10.1288/00005537-195403000-00001 [DOI] [PubMed] [Google Scholar]
  • 94.Sohl G, Maxeiner S, Willecke K (2005) Expression and functions of neuronal gap junctions. Nat Rev Neurosci 6(3):191–200. 10.1038/nrn1627 [DOI] [PubMed] [Google Scholar]
  • 95.Stojkovic T, Latour P, Vandenberghe A, Hurtevent JF, Vermersch P (1999) Sensorineural deafness in X-linked Charcot-Marie-Tooth disease with connexin 32 mutation (R142Q). Neurology 52(5):1010–1014 [DOI] [PubMed] [Google Scholar]
  • 96.Suga F, Nakashima T, Snow JB Jr. (1970) Sodium and potassium ions in endolymph. In vivo measurements with glass microelectrodes. Arch Otolaryngol 91(1):37–43 [DOI] [PubMed] [Google Scholar]
  • 97.Suzuki T, Takamatsu T, Oyamada M (2003) Expression of gap junction protein connexin43 in the adult rat cochlea: comparison with connexin26. J Histochem Cytochem 51(7):903–912 [DOI] [PubMed] [Google Scholar]
  • 98.Takeuchi S, Ando M (1998) Dye-coupling of melanocytes with endothelial cells and pericytes in the cochlea of gerbils. Cell Tissue Res 293(2):271–275 [DOI] [PubMed] [Google Scholar]
  • 99.Takeuchi S, Ando M (1998) Inwardly rectifying K+ currents in intermediate cells in the cochlea of gerbils: a possible contribution to the endocochlear potential. Neurosci Lett 247(2–3):175–178 [DOI] [PubMed] [Google Scholar]
  • 100.Takeuchi S, Ando M, Kakigi A (2000) Mechanism generating endocochlear potential: role played by intermediate cells in stria vascularis. Biophys J 79(5):2572–2582. 10.1016/S0006-3495(00)76497-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 101.Takeuchi S, Marcus DC, Wangemann P (1992) Ca(2+)-activated nonselective cation, maxi K+ and Cl- channels in apical membrane of marginal cells of stria vascularis. Hear Res 61(1–2):86–96 [DOI] [PubMed] [Google Scholar]
  • 102.Tasaki I, Spyropoulos CS (1959) Stria vascularis as source of endocochlear potential. J Neurophysiol 22(2):149–155 [DOI] [PubMed] [Google Scholar]
  • 103.Teubner B, Michel V, Pesch J, Lautermann J, Cohen-Salmon M, Sohl G, Jahnke K, Winterhager E, Herberhold C, Hardelin JP, Petit C, Willecke K (2003) Connexin30 (Gjb6)-deficiency causes severe hearing impairment and lack of endocochlear potential. Hum Mol Genet 12(1):13–21 [DOI] [PubMed] [Google Scholar]
  • 104.Uetsuka S, Ogata G, Nagamori S, Isozumi N, Nin F, Yoshida T, Komune S, Kitahara T, Kikkawa Y, Inohara H, Kanai Y, Hibino H (2015) Molecular architecture of the stria vascularis membrane transport system, which is essential for physiological functions of the mammalian cochlea. Eur J Neurosci 42(3):1984–2002. 10.1111/ejn.12973 [DOI] [PubMed] [Google Scholar]
  • 105.Vetter DE, Mann JR, Wangemann P, Liu J, McLaughlin KJ, Lesage F, Marcus DC, Lazdunski M, Heinemann SF, Barhanin J (1996) Inner ear defects induced by null mutation of the isk gene. Neuron 17(6):1251–1264 [DOI] [PubMed] [Google Scholar]
  • 106.Von Bekesy G (1952) Resting potentials inside the cochlear partition of the guinea pig. Nature 169(4293):241–242 [DOI] [PubMed] [Google Scholar]
  • 107.Wangemann P (1995) Comparison of ion transport mechanisms between vestibular dark cells and strial marginal cells. Hear Res 90(1–2):149–157 [DOI] [PubMed] [Google Scholar]
  • 108.Wangemann P (2002) K+ cycling and the endocochlear potential. Hear Res 165(1–2):1–9 [DOI] [PubMed] [Google Scholar]
  • 109.Wangemann P (2006) Supporting sensory transduction: cochlear fluid homeostasis and the endocochlear potential. J Physiol 576(Pt 1):11–21. 10.1113/jphysiol.2006.112888 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 110.Wangemann P, Itza EM, Albrecht B, Wu T, Jabba SV, Maganti RJ, Lee JH, Everett LA, Wall SM, Royaux IE, Green ED, Marcus DC (2004) Loss of KCNJ10 protein expression abolishes endocochlear potential and causes deafness in Pendred syndrome mouse model. BMC Med 2:30. 10.1186/1741-7015-2-30 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 111.Xia JH, Liu CY, Tang BS, Pan Q, Huang L, Dai HP, Zhang BR, Xie W, Hu DX, Zheng D, Shi XL, Wang DA, Xia K, Yu KP, Liao XD, Feng Y, Yang YF, Xiao JY, Xie DH, Huang JZ (1998) Mutations in the gene encoding gap junction protein beta-3 associated with autosomal dominant hearing impairment. Nat Genet 20(4):370–373. 10.1038/3845 [DOI] [PubMed] [Google Scholar]
  • 112.Xie Z, Ma XH, Bai QF, Tang J, Sun JH, Jiang F, Guo W, Wang CM, Yang R, Wen YC, Wang FY, Chen YX, Zhang H, He DZ, Kelley MW, Yang S, Zhang WJ (2023) ZBTB20 is essential for cochlear maturation and hearing in mice. Proc Natl Acad Sci USA 120(24):e2220867120. 10.1073/pnas.2220867120 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 113.Yoshida T, Nin F, Murakami S, Ogata G, Uetsuka S, Choi S, Nakagawa T, Inohara H, Komune S, Kurachi Y, Hibino H (2016) The unique ion permeability profile of cochlear fibrocytes and its contribution to establishing their positive resting membrane potential. Pflugers Arch. 10.1007/s00424-016-1853-2 [DOI] [PubMed] [Google Scholar]
  • 114.Yoshida T, Nin F, Ogata G, Uetsuka S, Kitahara T, Inohara H, Akazawa K, Komune S, Kurachi Y, Hibino H (2015) NKCCs in the fibrocytes of the spiral ligament are silent on the unidirectional K(+) transport that controls the electrochemical properties in the mammalian cochlea. Pflugers Arch 467(7):1577–1589. 10.1007/s00424-014-1597-9 [DOI] [PubMed] [Google Scholar]
  • 115.Zelante L, Gasparini P, Estivill X, Melchionda S, D’Agruma L, Govea N, Mila M, Monica MD, Lutfi J, Shohat M, Mansfield E, Delgrosso K, Rappaport E, Surrey S, Fortina P (1997) Connexin26 mutations associated with the most common form of non-syndromic neurosensory autosomal recessive deafness (DFNB1) in Mediterraneans. Hum Mol Genet 6(9):1605–1609 [DOI] [PubMed] [Google Scholar]
  • 116.Zhang Q, Ota T, Yoshida T, Ino D, Sato MP, Doi K, Horii A, Nin F, Hibino H (2021) Electrochemical properties of the non-excitable tissue stria vascularis of the mammalian cochlea are sensitive to sounds. J Physiol 599(19):4497–4516. 10.1113/JP281981 [DOI] [PubMed] [Google Scholar]
  • 117.Zhao HB, Kikuchi T, Ngezahayo A, White TW (2006) Gap junctions and cochlear homeostasis. J Membr Biol 209(2–3):177–186. 10.1007/s00232-005-0832-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 118.Zhu Y, Chen J, Liang C, Zong L, Chen J, Jones RO, Zhao HB (2015) Connexin26 (GJB2) deficiency reduces active cochlear amplification leading to late-onset hearing loss. Neuroscience 284:719–729. 10.1016/j.neuroscience.2014.10.061 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 119.Zidanic M, Brownell WE (1990) Fine structure of the intracochlear potential field. I. The silent current. Biophys J 57(6):1253–1268. 10.1016/S0006-3495(90)82644-8 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from JARO: Journal of the Association for Research in Otolaryngology are provided here courtesy of Springer

RESOURCES